What Happens If You Miss a Dose of Climara

What Happens If You Miss a Dose of Climara?

Short answer: Missing one weekly Climara patch is not an emergency. According to FDA-approved prescribing information for Climara, if a dose is missed, apply a patch as soon as you remember; if it is within about 24 hours, this may be enough to maintain steady estrogen levels and you may continue your weekly schedule. If it has been longer, apply a new patch now — a missed dose may allow return of menopausal symptoms such as hot flashes or may cause breakthrough bleeding. Do not apply two patches at once unless directed by your prescriber. Contact your prescriber if doses are missed repeatedly or if symptoms change.

Detailed explanation: Per FDA-approved prescribing information for Climara, Climara is a once‑weekly transdermal estradiol patch containing estradiol that releases estrogen through the skin. According to FDA-approved prescribing information for Climara, if the patch is missed or falls off, blood estradiol levels may decline and symptoms such as hot flashes, night sweats, or vaginal dryness may return; some women may also experience irregular or breakthrough bleeding. What to do depends on timing and circumstance: if the patch partially detaches, press it back onto clean, dry skin or replace it with the same patch if it is still adhesive and only a short time has passed. According to FDA-approved prescribing information for Climara, if the patch has been off or missed for less than about 24 hours, apply a patch immediately — this may restore levels without significant disruption. If it has been more than 24–48 hours, apply a new patch now; your weekly cycle will effectively restart from the day you apply it. Do not apply two patches at once unless directed by your prescriber. Missing one dose does not erase long‑term benefits such as bone protection, but repeated missed doses may reduce benefits over time. If you are on combined HRT (estrogen plus progestin) or on a cyclic regimen, missing estrogen may change bleeding patterns; contact your prescriber for personalized instructions. Per FDA-approved prescribing information for Climara, the FDA labeling describes serious events associated with estrogen-containing products — including cardiovascular events, deep vein thrombosis (DVT), pulmonary embolism (PE), endometrial cancer, breast cancer, and probable dementia in women 65 or older — as boxed warnings; patients who experience symptoms such as sudden leg swelling, chest pain, shortness of breath, sudden severe headache, or vision changes should contact their prescriber promptly. Whether any individual symptom warrants intervention depends on personal health factors that a clinician must assess, and published guidance from NAMS or ACOG informs how prescribers evaluate them. Contact your prescriber if doses are missed repeatedly or if symptoms change — your clinician or pharmacist may provide advice tailored to your situation and medical history.